Jonathan M J Derry, Lara M Mangravite, Christine Suver, Matthew D Furia, David Henderson, Xavier Schildwachter, Brian Bot, Jonathan Izant, Solveig K Sieberts, Michael R Kellen, Stephen H Friend (2012) Developing predictive molecular maps of human disease through community-based modeling, 127-130. In Nature Genetics 44 (2).
Ann L Oberg, Brian M Bot, Diane E Grill, Gregory A Poland, Terry M Therneau (2012) Technical and biological variance structure in mRNA-Seq data: life in the real world., 304. In BMC genomics 13 (1).
Qian Shi, Lindsay A. Renfro, Brian M. Bot, Tomasz Burzykowski, Marc Buyse, Daniel J. Sargent (2011) Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials, 2748-2757. In Computational Statistics & Data Analysis 55 (9).
Daniel J Sargent, Murray B Resnick, Michael O Meyers, Atoussa Goldar-Najafi, Thomas Clancy, Sharlene Gill, Gary O Siemons, Qian Shi, Brian M Bot, Tsung-Teh Wu, Guillaume Beaudry, Jean-François Haince, Yves Fradet (2011) Evaluation of Guanylyl Cyclase C Lymph Node Status for Colon Cancer Staging and Prognosis., 1-10. In Annals of surgical oncology.
Brian M Bot, Jeanette E Eckel-Passow, Shauna N Legrand, Tracy Hilton, John C Cheville, Todd Igel, Alexander S Parker (2011) Expression of endothelin 2 and localized clear cell renal cell carcinoma.. In Human pathology.
Charles D Blanke, Brian M Bot, David M Thomas, Archie Bleyer, Claus-Henning Kohne, Matthew T Seymour, Aimery de Gramont, Richard M Goldberg, Daniel J Sargent (2011) Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials., 2781-6. In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29 (20).
Zhifu Sun, Yan W Asmann, Krishna R Kalari, Brian Bot, Jeanette E Eckel-Passow, Tiffany R Baker, Jennifer M Carr, Irina Khrebtukova, Shujun Luo, Lu Zhang, Gary P Schroth, Edith A Perez, E Aubrey Thompson (2011) Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing., e17490. In PloS one 6 (2).
D Sargent, Q Shi, G Yothers, E Van Cutsem, J Cassidy, L Saltz, N Wolmark, B Bot, A Grothey, M Buyse, A de Gramont (2011) Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803., 990-6. In European journal of cancer (Oxford, England : 1990) 47 (7).
Aimery de Gramont, Joleen Hubbard, Qian Shi, Michael J O'Connell, Marc Buyse, Jacqueline Benedetti, Brian Bot, Chris O'Callaghan, Greg Yothers, Richard M Goldberg, Charles D Blanke, Al Benson, Qiqi Deng, Steven R Alberts, Thierry Andre, Norman Wolmark, Axel Grothey, Daniel Sargent (2010) Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set., 460-5. In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28 (3).
Shauna L Hillman, Sumithra J Mandrekar, Brian Bot, Ronald P DeMatteo, Edith A Perez, Karla V Ballman, Heidi Nelson, Jan C Buckner, Daniel J Sargent (2010) Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation., 3002-7. In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28 (18).
Julie M Cunningham, Ann L Oberg, Pedro M Borralho, Betsy T Kren, Amy J French, Liang Wang, Brian M Bot, Bruce W Morlan, Kevin A T Silverstein, Rod Staggs, Yan Zeng, Anne-Francoise Lamblin, Christopher A Hilker, Jian-Bing Fan, Clifford J Steer, Stephen N Thibodeau (2009) Evaluation of a new high-dimensional miRNA profiling platform., 57. In BMC medical genomics 2 (1).
Daniel J Sargent, Claus Henning Köhne, Hanna Kelly Sanoff, Brian M Bot, Matthew T Seymour, Aimery de Gramont, Ranier Porschen, Leonard B Saltz, Philippe Rougier, Christopher Tournigand, Jean-Yves Douillard, Richard J Stephens, Axel Grothey, Richard M Goldberg (2009) Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer., 1948-55. In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27 (12).
Yolanda I Garces, Scott H Okuno, Steven E Schild, Sumithra J Mandrekar, Brian M Bot, John M Martens, Donald B Wender, Gamini S Soori, Dennis F Moore, Timothy F Kozelsky, James R Jett (2007) Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer., 995-1001. In International journal of radiation oncology, biology, physics 67 (4).
Sumithra J Mandrekar, Donald W Northfelt, Steven E Schild, Nathan R Foster, Brian Bot, Randolph S Marks, James A Mailliard, James E Krook, Andrew W Maksymiuk, Alex A Adjei, James R Jett (2006) Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials., 556-63. In Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 1 (6).